Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: A Multicenter European Study

NCT04383678 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.

NCT NCT04383678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04383678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: A Multicenter European Study
Lead sponsor
Helsinki University Central Hospital
Phase
Observational
Overall status
Completed
Start date
March 1, 2020
Completion date
April 1, 2021
Enrollment
132 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, covid-19, extracorporeal membrane oxygenation complication